Celator Pharmaceuticals

After holiday weekend rumors, Jazz confirms $1.5B buyout of tiny Celator

The Wall Street Journal kicked off rumors over the Memorial Day weekend that Ireland’s Jazz Pharmaceuticals was set to buy Celator, and early this morning the two confirmed the $1.5 billion deal was to go ahead.

Ben Adams May 31, 2016 4:45am

FDA grants ‘Breakthrough’ status for Celator’s blood cancer drug

May 20, 2016 4:17am